Spectral Med Inc faced a significant downturn, with shares dropping over 7% in the latest trading session.
In yesterday's trading session, Spectral Med Inc (EDT.TO) experienced a sharp decline, closing down 7.09% at CA$1.31. This drop raises questions about the company's current standing and future prospects in the competitive healthcare market.
Advertisement
Spectral Med Inc
EDT.TO
EDT.TO
Spectral Med Inc
WealthAwesomeMarket cap
$384.56M
52W high
$1.76
52W low
$1.13
1W change
-5.76%
Beta
0.21
Analyst Price Targets
Based on analyst covering EDT
Wall Street analysts forecast EDT stock price to rise 140.5% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$3.15
+140.5% Upside
Current Price
C$1.31
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on EDT's historical volatility
30-Day Vol
33.0%
Annualized
90-Day Vol
29.1%
Annualized
Trend (90d)
-36.8%
Annualized drift
90d Mean
C$1.15
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$1.25 | C$1.12 – C$1.41 |
| 60 trading days | C$1.20 | C$1.02 – C$1.41 |
| 90 trading days | C$1.15 | C$0.94 – C$1.40 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: Investors should be cautious as the recent decline in Spectral Med's stock could indicate underlying challenges, particularly given the lack of recent positive news.
Spectral Med Inc Experiences a 7.09% Decline
The company's market cap now stands at CA$384.56 million, reflecting investor concerns following the recent stock performance.
Bull case
Spectral Med is actively working on commercializing its PMX product and pursuing FDA applications. If these efforts succeed, they could lead to significant growth for the company in the future.
Bear case
The recent stock performance suggests that investors are feeling skeptical, especially since there haven't been any positive developments or news to boost confidence lately.
Advertisement
Stock Performance Overview
Spectral Med Inc's stock plummeted by 7.09% yesterday, closing at CA$1.31. This decline is notable given the company's recent announcements regarding its PMX product and FDA applications. However, the lack of immediate positive news may have contributed to investor hesitation.
Market Sentiment and Future Outlook
With a market cap of CA$384.56 million, Spectral Med's recent performance reflects a growing skepticism among investors. The absence of significant updates or advancements in the company's projects could hinder future growth, making it essential for investors to monitor upcoming developments closely. For more insights, check the latest on EDT.TO.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
